ZYDUS LIFESCIENCES LIMITED

Business Segments Zydus Lifesciences Limited

Equities

ZYDUSLIFE

INE010B01027

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 04:35:10 05/06/2026 pm IST			5-day change	1st Jan Change
1,089.00 ^INR	+0.41%		+1.05%	+19.10%

03/06	Zydus Lifesciences Receives USFDA Warning Letter for Baddi Facility	MT
28/05	Zydus Lifesciences says US FDA grants priority review to Zydus Therapeutics' NDA for saroglitazar to treat pbc	RE

Sales 2025 by Business Segment

© MarketScreener.com See more

Sales 2025 by Geography

© MarketScreener.com See more

Historical Breakdown of Revenue by Business Segments

EBT: Breakdown by Business Segment

Breakdown by Business Segment (INR)

Fiscal Period: March	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Medicinal Chemicals and Botanical Products
Pharmaceuticals						13TCr	13TCr	15TCr	17TCr	21TCr
Total Assets						18TCr	22TCr	20TCr	23TCr	31TCr
Interest Expense						-	-	-	-	-
Income Tax Expense						-	-	-	-	-
CAPEX						-	-	-	-	-
EBT						2.25TCr	2.42TCr	2.89TCr	4.56TCr	5.9TCr
D&A						-	-	-	-	-
Net Income						-	-	-	-	-
Pharmaceutical Products
Consumer Products						1.84TCr	1.98TCr	2.24TCr	2.31TCr	2.7TCr
Total Assets						5.67TCr	5.69TCr	5.83TCr	6.15TCr	6.44TCr
EBT						244.3Cr	306Cr	300.9Cr	266.3Cr	347Cr

Geographical Revenue Distribution History

Geographical breakdown of sales (INR)

Fiscal Period: March	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
United States						6.54TCr	5.95TCr	7.49TCr	8.78TCr	11TCr
Total Assets						1.2TCr	897.1Cr	356Cr	392.1Cr	681.3Cr
CAPEX						-	-	-	-	-
India						6.46TCr	7.25TCr	7.64TCr	8.02TCr	9.25TCr
Total Assets						11TCr	12TCr	12TCr	14TCr	15TCr
CAPEX						-	-	-	-	-
Others						2.1TCr	2.06TCr	2.11TCr	2.76TCr	2.85TCr
Total Assets						479.8Cr	494.1Cr	516.4Cr	485.9Cr	397.4Cr
CAPEX						-	-	-	-	-

The best tools reserved for subscribers to boost the performance of your investments!